J&J Takes Ebola Vaccine Into Phase III

The Johnson & Johnson company, Janssen Pharmaceutical, has started a Phase III trial of its Ebola vaccine in Sierra Leone – pushing on with R&D for the candidate despite the initial Ebola crisis having calmed and other big players developing competing late-stage immunization options.